{"title":"STAT+: Dispute between Corcept Therapeutics, FDA runs deep","path":"/2026/02/05/corcept-therapeutics-fda-relacorilant-cushings-disease/?utm_campaign=rss","site":"https://www.statnews.com","atUri":"at://did:plc:5ka4qkui7nvjms7idhte2m4o/site.standard.document/3me6dlghbedz2","publishedAt":"2026-02-05T11:30:00Z","tags":"Adam's Biotech Scorecard;Adam's Take;Biotech;biotechnology;Cancer;chronic disease;Pharmaceuticals;rare diseases;STAT+"}